Vanguard Group’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
27,529
+3,092
| +13% | +$24.1K | ﹤0.01% | 4079 |
|
|
2025
Q1 | $229K | Buy |
+24,437
| New | +$229K | ﹤0.01% | 4043 |
|
|
2024
Q4 | – | Sell |
-5,038
| Closed | -$18.1K | – | 4299 |
|
|
2024
Q3 | $18.1K | Hold |
5,038
| – | – | ﹤0.01% | 4307 |
|
|
2024
Q2 | $29.1K | Sell |
5,038
-397
| -7% | -$2.3K | ﹤0.01% | 4336 |
|
|
2024
Q1 | $32.3K | Hold |
5,435
| – | – | ﹤0.01% | 4354 |
|
|
2023
Q4 | $85.2K | Buy |
5,435
+954
| +21% | +$15K | ﹤0.01% | 4317 |
|
|
2023
Q3 | $104K | Buy |
4,481
+397
| +10% | +$9.21K | ﹤0.01% | 4344 |
|
|
2023
Q2 | $127K | Hold |
4,084
| – | – | ﹤0.01% | 4369 |
|
|
2023
Q1 | $118K | Buy |
+4,084
| New | +$118K | ﹤0.01% | 4388 |
|